Name
Männi Hambaravi OÜ
Registry code
11801174
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.12.2009 (14)
Financial year
01.01-31.12
Capital
2 558.00 €
Activity
86231 - Provision of dental treatment
113 523 €
36 573 €
32%
1 291 €
(estimate is approximate)
94 922 €
2
Submitted
No tax arrears
39%
38%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Lily Tuisk 19.09.1961 (63) | 100% - 2 558.00 EUR | Board member | Member of a higher management body, i.e. board member or supervisory board member | Founder |
| Signe Pius 13.10.1961 (63) | - | - | - | Auditor who has assessed non-monetary contribution |
| Milvi Ristoja 08.04.1939 (85) | - | - | - | Founder |
| 2019 01.06.2020 | 2020 28.06.2021 | 2021 21.06.2022 | 2022 01.06.2023 | 2023 01.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 99 072 € | 87 254 € | 97 986 € | 113 328 € | 113 523 € |
| Net profit (loss) for the period | 29 693 € | 13 266 € | 18 071 € | 34 583 € | 36 573 € |
| Profit Margin | 30% | 15% | 18% | 31% | 32% |
| Current Assets | 52 922 € | 59 344 € | 68 718 € | 78 779 € | 97 501 € |
| Fixed Assets | 17 048 € | 12 504 € | 7 960 € | 3 416 € | 0 € |
| Total Assets | 69 970 € | 71 848 € | 76 678 € | 82 195 € | 97 501 € |
| Current Liabilities | 1 781 € | 4 393 € | 1 152 € | 2 086 € | 2 579 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 68 189 € | 67 455 € | 75 526 € | 80 109 € | 94 922 € |
| Employees | 3 | 3 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 8 399.83 € | 5 219.16 € | 3 |
| 2023 Q4 | - | 4 632.15 € | 4 274.16 € | 3 |
| 2023 Q3 | - | 4 981.34 € | 4 379.16 € | 3 |
| 2023 Q2 | - | 4 529.81 € | 3 505.06 € | 3 |
| 2023 Q1 | - | 4 133.07 € | 3 085.06 € | 3 |
| 2022 Q4 | - | 3 400.28 € | 3 015.06 € | 3 |
| 2022 Q3 | - | 3 900.28 € | 3 015.06 € | 3 |
| 2022 Q2 | - | 6 463.86 € | 3 375.34 € | 3 |
| 2022 Q1 | - | 4 064.23 € | 3 365.06 € | 3 |
| 2021 Q4 | - | 4 907.43 € | 4 070.4 € | 3 |
| 2021 Q3 | - | 4 106.16 € | 4 340.4 € | 3 |
| 2021 Q2 | - | 5 270.11 € | 4 690.4 € | 3 |
| 2021 Q1 | - | 4 105.98 € | 4 340.22 € | 3 |
| 2020 Q4 | - | 5 105.01 € | 3 815.64 € | 3 |
| 2020 Q3 | - | 4 001.06 € | 3 166.75 € | 3 |
| 2020 Q2 | - | 3 206.95 € | 2 971.9 € | 3 |
| 2020 Q1 | - | 4 596.66 € | 3 980.86 € | 3 |
